Background illustration for clinical trials search

Paid Clinical Trials Fort Collins

Discover 1,283 paid clinical trials in Fort Collins, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Denver CO, Aurora CO, Oklahoma City OK, Fairway KS,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

for
Multiple Myeloma
Location: Denver CO, San Francisco CA, Seattle WA, Cleveland OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06500884

Phase 2, Recruiting

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

for
Multiple Myeloma
Location: Denver CO, Scottsdale AZ, Minneapolis MN, Rochester MN,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07095452

Phase 2, Phase 3, Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for
Relapsed or Refractory Multiple Myeloma,
Location: Denver CO, Duarte CA, Irvine CA, Houston TX,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05652335

Phase 1, Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

for
Relapsed/Refractory B-cell Malignancies
Location: Denver CO, Dallas TX, Portland OR, Seattle WA,
Sponsor: Accutar Biotechnology Inc

Sex: All

Age: 18+

Code: NCT05780034

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Denver CO, Rochester MN, Duarte CA, Los Angeles CA,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase 1, Phase 2, Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for
Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,
Location: Denver CO, Salt Lake City UT, Albuquerque NM, Omaha NE,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase 1, Phase 2, Recruiting

The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population

for
Kidney Injury
Location: Denver CO, Boston MA
Sponsor: BioPorto Diagnostics

Sex: All

Age: 18+

Code: NCT03057457

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute,
Location: Denver CO, Salt Lake City UT, Calgary, Newport Beach CA,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 12+

Code: NCT04988555

Phase 1, Phase 2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Westwood KS, Gilbert AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Denver CO, Salt Lake City UT, Kansas City KS, Tucson AZ,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase 3, Recruiting

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: Denver CO, Sarasota FL, New York NY
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT05463263

Phase 1, Phase 2, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Tucson AZ, Minneapolis MN, Tyler TX,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase 2, Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for
Relapsed/Refractory Systemic Light Chain Amyloidosis
Location: Denver CO, Duarte CA, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06292780

Phase 1, Phase 2, Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Duarte CA, Milwaukee WI, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase 1, Recruiting

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

for
Advanced Malignant Solid Neoplasm, RAS Mutation, Lung Cancer,
Location: Denver CO, Los Angeles CA, Nashville TN
Sponsor: RasCal Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04678648

Phase 1, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Denver CO, Aurora CO, Saint Louis MO, Houston TX,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase 1, Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT04910568

Phase 1, Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma (MM), Multiple Myeloma Refractory,
Location: Denver CO, Las Vegas NV, Eugene OR, Nashville TN,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07637578

Phase 2, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Goodyear AZ, St Louis MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase 2, Recruiting